{"id":2094,"date":"2025-08-14T13:35:19","date_gmt":"2025-08-14T13:35:19","guid":{"rendered":"https:\/\/blogs.bmj.com\/jmg\/?p=2094"},"modified":"2026-02-22T01:00:30","modified_gmt":"2026-02-22T01:00:30","slug":"exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/","title":{"rendered":"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC)"},"content":{"rendered":"<p>Our study examines a potential link between BRIP1 pathogenic germline variants (PGVs) and central nervous system (CNS) tumors through a retrospective review of institutional germline and somatic databases. We found that 16.3% of families with BRIP1 PGVs reported CNS tumors. Somatic BRIP1 variants were rare in CNS tumors, but one of two individuals subsequently germline tested, was confirmed to carry a germline BRIP1 PGV. Although current data are insufficient to confirm or refute an association, documenting clinical and pathological features of CNS tumors in BRIP1 carriers and families is essential for future research exploring a possible connection. (<a href=\"https:\/\/jmg.bmj.com\/content\/early\/2025\/08\/07\/jmg-2025-110764\">https:\/\/jmg.bmj.com\/content\/early\/2025\/08\/07\/jmg-2025-110764<\/a> )<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Our study examines a potential link between BRIP1 pathogenic germline variants (PGVs) and central nervous system (CNS) tumors through a retrospective review of institutional germline and somatic databases. We found that 16.3% of families with BRIP1 PGVs reported CNS tumors. Somatic BRIP1 variants were rare in CNS tumors, but one of two individuals subsequently germline [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2094","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC) - JMG Contact blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC) - JMG Contact blog\" \/>\n<meta property=\"og:description\" content=\"Our study examines a potential link between BRIP1 pathogenic germline variants (PGVs) and central nervous system (CNS) tumors through a retrospective review of institutional germline and somatic databases. We found that 16.3% of families with BRIP1 PGVs reported CNS tumors. Somatic BRIP1 variants were rare in CNS tumors, but one of two individuals subsequently germline [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/\" \/>\n<meta property=\"og:site_name\" content=\"JMG Contact blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-14T13:35:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-22T01:00:30+00:00\" \/>\n<meta name=\"author\" content=\"hqqu\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@HuiQiQu\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"hqqu\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/\"},\"author\":{\"name\":\"hqqu\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\"},\"headline\":\"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC)\",\"datePublished\":\"2025-08-14T13:35:19+00:00\",\"dateModified\":\"2026-02-22T01:00:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/\"},\"wordCount\":127,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/\",\"name\":\"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC) - JMG Contact blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\"},\"datePublished\":\"2025-08-14T13:35:19+00:00\",\"dateModified\":\"2026-02-22T01:00:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/2025\\\/08\\\/14\\\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"name\":\"JMG Contact blog\",\"description\":\"JMG Contact blog\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#organization\",\"name\":\"JMG Contact blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/files\\\/2017\\\/10\\\/blog-logo-jmg.png\",\"width\":300,\"height\":34,\"caption\":\"JMG Contact blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/#\\\/schema\\\/person\\\/be0250f8d5b52412c3e7c222dabd591b\",\"name\":\"hqqu\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g\",\"caption\":\"hqqu\"},\"description\":\"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.\",\"sameAs\":[\"https:\\\/\\\/x.com\\\/HuiQiQu\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/jmg\\\/author\\\/hqiqu\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC) - JMG Contact blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/","og_locale":"en_US","og_type":"article","og_title":"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC) - JMG Contact blog","og_description":"Our study examines a potential link between BRIP1 pathogenic germline variants (PGVs) and central nervous system (CNS) tumors through a retrospective review of institutional germline and somatic databases. We found that 16.3% of families with BRIP1 PGVs reported CNS tumors. Somatic BRIP1 variants were rare in CNS tumors, but one of two individuals subsequently germline [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/","og_site_name":"JMG Contact blog","article_published_time":"2025-08-14T13:35:19+00:00","article_modified_time":"2026-02-22T01:00:30+00:00","author":"hqqu","twitter_card":"summary_large_image","twitter_creator":"@HuiQiQu","twitter_misc":{"Written by":"hqqu","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/"},"author":{"name":"hqqu","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b"},"headline":"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC)","datePublished":"2025-08-14T13:35:19+00:00","dateModified":"2026-02-22T01:00:30+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/"},"wordCount":127,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/","url":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/","name":"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC) - JMG Contact blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#website"},"datePublished":"2025-08-14T13:35:19+00:00","dateModified":"2026-02-22T01:00:30+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/jmg\/2025\/08\/14\/exploration-of-possible-association-of-brip1-pathogenic-variants-with-central-nervous-system-cancers-in-an-institutional-cohort\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/jmg\/"},{"@type":"ListItem","position":2,"name":"Exploration of possible association of BRIP1 pathogenic variants with central nervous system cancers in an institutional cohort (Contributed by Jackie Cappadocia, MS, LCGC)"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/jmg\/#website","url":"https:\/\/blogs.bmj.com\/jmg\/","name":"JMG Contact blog","description":"JMG Contact blog","publisher":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/jmg\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/jmg\/#organization","name":"JMG Contact blog","url":"https:\/\/blogs.bmj.com\/jmg\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","contentUrl":"https:\/\/blogs.bmj.com\/jmg\/files\/2017\/10\/blog-logo-jmg.png","width":300,"height":34,"caption":"JMG Contact blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/jmg\/#\/schema\/person\/be0250f8d5b52412c3e7c222dabd591b","name":"hqqu","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/920bc4e81500cde88def4bfd7775029cb154e422c5460b9cf80d5c47137d6f35?s=96&d=mm&r=g","caption":"hqqu"},"description":"Huiqi Qu has a background as a physician trained in internal medicine and a PhD in Experimental Medicine (Endocrinology). His research applies human genetics and multi-omics to complex and pediatric diseases, including GWAS, polygenic risk scores (PRS), single-cell transcriptomics, and integrative genomics to support precision medicine and clinical translation.","sameAs":["https:\/\/x.com\/HuiQiQu"],"url":"https:\/\/blogs.bmj.com\/jmg\/author\/hqiqu\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/2094","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/comments?post=2094"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/posts\/2094\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/media?parent=2094"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/categories?post=2094"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/jmg\/wp-json\/wp\/v2\/tags?post=2094"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}